To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics
Department of Neurosurgery, University of Pécs, Pécs, Hungary.
Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States.
Department of Neurosurgery, University of Pécs, Pécs, Hungary; Neurobiology Research Group, Hungarian Academy of Sciences, Pécs, Hungary.
Department of Neurosurgery, University of Pécs, Pécs, Hungary.
Show others and affiliations
2010 (English)In: Acta Neurochirurgica, ISSN 0001-6268, E-ISSN 0942-0940, Vol. 152, no 1, p. 1-17Article, review/survey (Refereed) Published
Abstract [en]

Purpose: This review summarizes protein biomarkers in mild and severe traumatic brain injury in adults and children and presents a strategy for conducting rationally designed clinical studies on biomarkers in head trauma.

Methods: We performed an electronic search of the National Library of Medicine's MEDLINE and Biomedical Library of University of Pennsylvania database in March 2008 using a search heading of traumatic head injury and protein biomarkers. The search was focused especially on protein degradation products (spectrin breakdown product, c-tau, amyloid-beta(1-42)) in the last 10 years, but recent data on "classical" markers (S-100B, neuron-specific enolase, etc.) were also examined.

Results: We identified 85 articles focusing on clinical use of biomarkers; 58 articles were prospective cohort studies with injury and/or outcome assessment.

Conclusions: We conclude that only S-100B in severe traumatic brain injury has consistently demonstrated the ability to predict injury and outcome in adults. The number of studies with protein degradation products is insufficient especially in the pediatric care. Cohort studies with well-defined end points and further neuroproteomic search for biomarkers in mild injury should be triggered. After critically reviewing the study designs, we found that large homogenous patient populations, consistent injury, and outcome measures prospectively determined cutoff values, and a combined use of different predictors should be considered in future studies.

Place, publisher, year, edition, pages
Springer, 2010. Vol. 152, no 1, p. 1-17
National Category
Neurology
Identifiers
URN: urn:nbn:se:oru:diva-113424DOI: 10.1007/s00701-009-0463-6ISI: 000273305600001PubMedID: 19652904Scopus ID: 2-s2.0-74249090631OAI: oai:DiVA.org:oru-113424DiVA, id: diva2:1855030
Note

This work was supported by the Hungarian Science Funds (OTKA T048724/2005 and OTKA 72240). 

Available from: 2024-04-29 Created: 2024-04-29 Last updated: 2024-04-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Büki, Andras

Search in DiVA

By author/editor
Büki, Andras
In the same journal
Acta Neurochirurgica
Neurology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf